Trial · NCT05419115
Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
NCT05419115, Phase 2, Completed, NHS Greater Glasgow and Clyde
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure. Trials, record NCT05419115. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05419115
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
- NCT number
- NCT05419115
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 172 participants, actual
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Conditions
- Heart Failure
- Interventions
- SQIN-Furosemide, SQIN-Infusor
- First posted
- 2022-06-15
- Last updated
- 2026-03-30
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Days Alive Out of Hospital | 30 days | Days spent alive and out of hospital (DAOH), from randomisation to 30 days. |
| Secondary | Length of index hospitalisation | 30 days | Length of index hospitalisation |
| Secondary | Change in quality of life | 60 days | Change in quality of life at 60 days (assessed by Kansas City Cardiomyopathy Questionnaire \[KCCQ-12\]) \[0-100\] |
| Secondary | Days Alive Out of Hospital | 60 days | Days spent alive and out of hospital (DAOH), from randomisation to 60 days. |
| Secondary | Total number of HF hospitalisations at 60 days | 60 days | Total number of HF hospitalisations at 60 days |
| Secondary | CV death or first HF hospitalisation at 60 days | 60 days | CV death or first HF hospitalisation at 60 days |
| Secondary | CV mortality at 60 days | 60 days | CV mortality at 60 days |
| Secondary | Safety as determined by treatment emergent adverse events (TEAEs) (including serious adverse events [SAEs]) and adverse drug events (ADEs) (including serious adverse drug events [SADEs]) | 60 days | Safety as determined by treatment emergent adverse events (TEAEs) (including serious adverse events \[SAEs\]) and adverse drug events (ADEs) (including serious adverse drug events \[SADEs\]) |
| Secondary | Any device failures (e.g., adhesive failure and drug delivery failure) | 60 days | Any device failures (e.g., adhesive failure and drug delivery failure) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers2
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05419115
GET https://conductscience.org/api/trials/v1/NCT05419115/registered